Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information

Hong Yang¹, Chu Qin², Ying Hong Li³, Lin Tao², Jin Zhou³, Chun Yan Yu³, Feng Xu⁴, Zhe Chen⁵, Feng Zhu⁶, Yu Zong Chen⁷

Affiliations

¹ Bioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, 117543, Singapore Innovative Drug Research Centre and College of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, P. R. China.
² Bioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, 117543, Singapore.
³ Innovative Drug Research Centre and College of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, P. R. China.
⁴ College of Pharmacy, State Key Laboratory of Medicinal Chemical Biology and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300071, P. R. China.
⁵ Zhejiang Key Laboratory of Gastro-intestinal Pathophysiology, Zhejiang Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University, No. 54 Youdian Road, Hangzhou 310006, China.
⁶ Bioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, 117543, Singapore Innovative Drug Research Centre and College of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, P. R. China zhufeng@cqu.edu.cn.
⁷ Bioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, 117543, Singapore csccyz@nus.edu.sg.

PMID: 26578601
PMCID: PMC4702870
DOI: 10.1093/nar/gkv1230

Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information

Hong Yang et al. Nucleic Acids Res. 2016.

. 2016 Jan 4;44(D1):D1069-74.

doi: 10.1093/nar/gkv1230. Epub 2015 Nov 17.

Authors

Hong Yang¹, Chu Qin², Ying Hong Li³, Lin Tao², Jin Zhou³, Chun Yan Yu³, Feng Xu⁴, Zhe Chen⁵, Feng Zhu⁶, Yu Zong Chen⁷

Affiliations

¹ Bioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, 117543, Singapore Innovative Drug Research Centre and College of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, P. R. China.
² Bioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, 117543, Singapore.
³ Innovative Drug Research Centre and College of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, P. R. China.
⁴ College of Pharmacy, State Key Laboratory of Medicinal Chemical Biology and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300071, P. R. China.
⁵ Zhejiang Key Laboratory of Gastro-intestinal Pathophysiology, Zhejiang Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University, No. 54 Youdian Road, Hangzhou 310006, China.
⁶ Bioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, 117543, Singapore Innovative Drug Research Centre and College of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, P. R. China zhufeng@cqu.edu.cn.
⁷ Bioinformatics and Drug Design Group, Department of Pharmacy, and Center for Computational Science and Engineering, National University of Singapore, 117543, Singapore csccyz@nus.edu.sg.

PMID: 26578601
PMCID: PMC4702870
DOI: 10.1093/nar/gkv1230

Abstract

Extensive drug discovery efforts have yielded many approved and candidate drugs targeting various targets in different biological pathways. Several freely accessible databases provide the drug, target and drug-targeted pathway information for facilitating drug discovery efforts, but there is an insufficient coverage of the clinical trial drugs and the drug-targeted pathways. Here, we describe an update of the Therapeutic Target Database (TTD) previously featured in NAR. The updated contents include: (i) significantly increased coverage of the clinical trial targets and drugs (1.6 and 2.3 times of the previous release, respectively), (ii) cross-links of most TTD target and drug entries to the corresponding pathway entries of KEGG, MetaCyc/BioCyc, NetPath, PANTHER pathway, Pathway Interaction Database (PID), PathWhiz, Reactome and WikiPathways, (iii) the convenient access of the multiple targets and drugs cross-linked to each of these pathway entries and (iv) the recently emerged approved and investigative drugs. This update makes TTD a more useful resource to complement other databases for facilitating the drug discovery efforts. TTD is accessible at http://bidd.nus.edu.sg/group/ttd/ttd.asp.

PubMed Disclaimer

Figures

**Figure 1.**
The pathway affiliation search page of the therapeutic target database.

See this image and copyright information in PMC

Cited by

In silico repositioning of approved drugs against Schistosoma mansoni energy metabolism targets.
Calixto NM, Dos Santos DB, Bezerra JCB, Silva LA. Calixto NM, et al. PLoS One. 2018 Dec 31;13(12):e0203340. doi: 10.1371/journal.pone.0203340. eCollection 2018. PLoS One. 2018. PMID: 30596650 Free PMC article.
Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target.
Li XX, Yin J, Tang J, Li Y, Yang Q, Xiao Z, Zhang R, Wang Y, Hong J, Tao L, Xue W, Zhu F. Li XX, et al. Front Pharmacol. 2018 Oct 31;9:1245. doi: 10.3389/fphar.2018.01245. eCollection 2018. Front Pharmacol. 2018. PMID: 30429792 Free PMC article.
VARIDT 1.0: variability of drug transporter database.
Yin J, Sun W, Li F, Hong J, Li X, Zhou Y, Lu Y, Liu M, Zhang X, Chen N, Jin X, Xue J, Zeng S, Yu L, Zhu F. Yin J, et al. Nucleic Acids Res. 2020 Jan 8;48(D1):D1042-D1050. doi: 10.1093/nar/gkz779. Nucleic Acids Res. 2020. PMID: 31495872 Free PMC article.
A New Strategy to Uncover the Anticancer Mechanism of Chinese Compound Formula by Integrating Systems Pharmacology and Bioinformatics.
Dai Y, Sun L, Qiang W. Dai Y, et al. Evid Based Complement Alternat Med. 2018 Jul 18;2018:6707850. doi: 10.1155/2018/6707850. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30108661 Free PMC article.
SMMDB: a web-accessible database for small molecule modulators and their targets involved in neurological diseases.
Mishra SK, Jain N, Shankar U, Tawani A, Mishra A, Kumar A. Mishra SK, et al. Database (Oxford). 2018 Jan 1;2018:1-12. doi: 10.1093/database/bay082. Database (Oxford). 2018. PMID: 30219840 Free PMC article.

See all "Cited by" articles

References

1. Hopkins A.L., Groom C.R. The druggable genome. Nat. Rev. Drug Discov. 2002;1:727–730. - PubMed
1. Imming P., Sinning C., Meyer A. Drugs, their targets and the nature and number of drug targets. Nat. Rev. Drug Discov. 2006;5:821–834. - PubMed
1. Zheng C.J., Han L.Y., Yap C.W., Ji Z.L., Cao Z.W., Chen Y.Z. Therapeutic targets: progress of their exploration and investigation of their characteristics. Pharmacol. Rev. 2006;58:259–279. - PubMed
1. Engelman J.A., Zejnullahu K., Mitsudomi T., Song Y., Hyland C., Park J.O., Lindeman N., Gale C.M., Zhao X., Christensen J., et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science. 2007;316:1039–1043. - PubMed
1. Chen Z., Cheng K., Walton Z., Wang Y., Ebi H., Shimamura T., Liu Y., Tupper T., Ouyang J., Li J., et al. A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature. 2012;483:613–617. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information

Affiliations

Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information

Authors

Affiliations

Abstract

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Research Materials